IL18 and esophageal squamous cell carcinoma: Increased levels of IL-6 9-11, IL-1 12, IL-8 13, IL-12 and IL-18 14 have been reported in the plasma in ESCC patients and correlated to poor prognosis or adverse clinical (or pathological) changes in ESCC.